Diabetic retinopathy.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  New England Journal of Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJMra1005073PMID 22455417
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• National Institute of Child Health and Human Development

  2013cited by this paper
• A phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema.

  2011cited by this paper
• Plasma Kallikrein Mediates Retinal Vascular Dysfunction and Induces Retinal Thickening in Diabetic Rats

  2011cited by this paper
• The influence of diabetes on glutamate metabolism in retinas

  2011cited by this paper
• Differential Roles of Hyperglycemia and Hypoinsulinemia in Diabetes Induced Retinal Cell Death: Evidence for Retinal Insulin Resistance

  2011cited by this paper
• Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial.

  2011cited by this paper
• Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies

  2011cited by this paper
• Review: Molecular pathogenesis of blood–brain barrier breakdown in acute brain injury

  2011cited by this paper
• Retinal function in relation to improved glycaemic control in type 1 diabetes

  2011cited by this paper
• Growth factors in the pathogenesis of diabetic nephropathy

  2011cited by this paper
• Prediction, by retinal location, of the onset of diabetic edema in patients with nonproliferative diabetic retinopathy.

  2011cited by this paper
• Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients

  2010cited by this paper
• The neurovascular unit in the setting of stroke

  2010cited by this paper
• The 25-year incidence of visual impairment in type 1 diabetes mellitus the wisconsin epidemiologic study of diabetic retinopathy.

  2010cited by this paper
• Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes.

  2010cited by this paper
• Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study.

  2010cited by this paper
• Beyond hemoglobin A1c--need for additional markers of risk for diabetic microvascular complications.

  2010cited by this paper
• The prevalence of retinopathy in men with Type 2 diabetes and obstructive sleep apnoea

  2010cited by this paper
• High Levels of Serum Prolactin Protect Against Diabetic Retinopathy by Increasing Ocular Vasoinhibins

  2010cited by this paper
• Antipermeability function of PEDF involves blockade of the MAP kinase/GSK/beta-catenin signaling pathway and uPAR expression.

  2010cited by this paper
• Effects of medical therapies on retinopathy progression in type 2 diabetes.

  2010cited by this paper
• TNF-α Signals Through PKCζ/NF-κB to Alter the Tight Junction Complex and Increase Retinal Endothelial Cell Permeability

  2010cited by this paper
• Müller Cell-Derived VEGF Is Essential for Diabetes-Induced Retinal Inflammation and Vascular Leakage

  2010cited by this paper
• Are Individuals With Diabetes Seeing Better?

  2010cited by this paper
• Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy.

  2009cited by this paper
• Occludin Phosphorylation and Ubiquitination Regulate Tight Junction Trafficking and Vascular Endothelial Growth Factor-induced Permeability*

  2009cited by this paper
• Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005).

  2009cited by this paper
• Activation of PKC-δ and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy

  2009cited by this paper
• Diabetic macular oedema and visual loss: relationship to location, severity and duration

  2009cited by this paper
• Inflammatory, Hemostatic, and Other Novel Biomarkers for Diabetic Retinopathy

  2009cited by this paper
• Trends in blood pressure control and treatment among type 2 diabetes with comorbid hypertension in the United States: 1988–2004

  2009cited by this paper
• Trends in medication use among US adults with diabetes mellitus: glycemic control at the expense of controlling cardiovascular risk factors.

  2009cited by this paper
• Müller cell‐derived VEGF is a significant contributor to retinal neovascularization

  2009cited by this paper
• Renal and retinal effects of enalapril and losartan in type 1 diabetes.

  2009cited by this paper
• Tissue plasminogen activator‐mediated PDGF signaling and neurovascular coupling in stroke

  2009cited by this paper
• Deficient activation and different expression of transforming growth factor-β isoforms in active proliferative diabetic retinopathy and neovascular eye disease

  2009influential reference
• Diabetes reduces autophosphorylation of retinal insulin receptor and increases protein-tyrosine phosphatase-1B activity.

  2009cited by this paper
• Diabetes downregulates presynaptic proteins and reduces basal synapsin I phosphorylation in rat retina

  2008cited by this paper
• Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications

  2008cited by this paper
• Changes in incidence of diabetes mellitus-related eye disease among US elderly persons, 1994-2005.

  2008cited by this paper
• Rapid, noninvasive detection of diabetes-induced retinal metabolic stress.

  2008cited by this paper
• The blood-brain barrier in health and chronic neurodegenerative disorders.

  2008cited by this paper
• The Angio-Fibrotic Switch of VEGF and CTGF in Proliferative Diabetic Retinopathy

  2008cited by this paper
• Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials.

  2008cited by this paper
• Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial.

  2008cited by this paper
• Serum levels of adiponectin are associated with diabetic retinopathy and with adiponectin gene mutations in Caucasian patients with diabetes mellitus type 2.

  2008cited by this paper
• Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits.

  2008cited by this paper
• The role of Humphrey Matrix testing in the early diagnosis of retinopathy in type 1 diabetes

  2008cited by this paper
• Identification of a Retinal Aldosterone System and the Protective Effects of Mineralocorticoid Receptor Antagonism on Retinal Vascular Pathology

  2008cited by this paper
• Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2 Akita diabetic mice.

  2008cited by this paper
• Microglial activation in human diabetic retinopathy.

  2008cited by this paper
• Regulation of retinal blood flow in health and disease.

  2008cited by this paper
• Glucocorticoids induce transactivation of tight junction genes occludin and claudin-5 in retinal endothelial cells via a novel cis-element.

  2008cited by this paper
• Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.

  2007cited by this paper
• Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema.

  2007cited by this paper
• Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial.

  2007cited by this paper
• Proteolytic Degradation of VE-Cadherin Alters the Blood-Retinal Barrier in Diabetes

  2007cited by this paper
• Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation

  2007cited by this paper
• Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy.

  2006cited by this paper
• Inflammation and metabolic disorders

  2006cited by this paper
• Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy

  2006cited by this paper
• VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability.

  2006cited by this paper
• Diabetes reduces basal retinal insulin receptor signaling: reversal with systemic and local insulin.

  2006cited by this paper
• [Surgical management of macular edema].

  2005cited by this paper
• The Blood-Brain Barrier/Neurovascular Unit in Health and Disease

  2005cited by this paper
• Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.

  2005cited by this paper
• Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes—the EURODIAB Prospective Complications Study

  2005cited by this paper
• Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study, I.

  2005cited by this paper
• Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.

  2004cited by this paper
• Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes—the Linköping Diabetes Complications Study

  2004cited by this paper
• The prevalence of diabetic retinopathy among adults in the United States.

  2004cited by this paper
• INTRAVITREAL TRIAMCINOLONE ACETONIDE FOR DIABETIC DIFFUSE MACULAR EDEMA

  2004cited by this paper
• Local multifocal oscillatory potential abnormalities in diabetes and early diabetic retinopathy.

  2004cited by this paper
• Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

  2004cited by this paper
• Altered Insulin Signaling in Retinal Tissue in Diabetic States*

  2004cited by this paper
• Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells.

  2004cited by this paper
• Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes.

  2004cited by this paper
• Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy

  2004cited by this paper
• Intravitreal injection of triamcinolone for diffuse diabetic macular edema.

  2003cited by this paper
• [Blood pressure control and diabetic retinopathy].

  2003cited by this paper
• Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.

  2003cited by this paper
• Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes.

  2003cited by this paper
• Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.

  2002cited by this paper
• PRECLINICAL AND PHASE 1A CLINICAL EVALUATION OF AN ANTI-VEGF PEGYLATED APTAMER (EYE001) FOR THE TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION

  2002cited by this paper
• Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy

  2002cited by this paper
• Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin

  2002cited by this paper
• Angiotensin-converting enzyme inhibition for the treatment of moderate to severe diabetic retinopathy in normotensive Type 2 diabetic patients. A pilot study.

  2002cited by this paper
• Clinical evaluation of patients with diabetic retinopathy: accuracy of the Inoveon diabetic retinopathy-3DT system.

  2002cited by this paper
• The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy?

  2002cited by this paper
• Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes.

  2002cited by this paper
• Intravitreal triamcinolone for refractory diabetic macular edema.

  2002cited by this paper
• Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.

  2002cited by this paper
• Endothelium‐specific platelet‐derived growth factor‐B ablation mimics diabetic retinopathy

  2002cited by this paper
• A fundus camera dedicated to the screening of diabetic retinopathy in the primary-care physician's office.

  2002cited by this paper
• Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppression

  2002cited by this paper
• Stereo nonmydriatic digital-video color retinal imaging compared with Early Treatment Diabetic Retinopathy Study seven standard field 35-mm stereo color photos for determining level of diabetic retinopathy.

  2001cited by this paper
• Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor

  2001cited by this paper
• [Diabetic retinopathy].

  2001influential reference
• Macular traction detachment and diabetic macular edema associated with posterior hyaloidal traction.

  2001cited by this paper
• Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C.

  2001cited by this paper

• Exposure to Type 1 and Type 2 Maternal Diabetes is Associated with Stage 3-5 Retinopathy of Prematurity

  2026cites this paper
• Neuroprotection in Diabetes Retinal Disease: An Unmet Medical Need

  2026cites this paper
• Total cholesterol, high-density lipoprotein, and glucose (CHG) index and diabetic retinopathy in middle-aged and elderly Chinese adults with diabetes: a cross-sectional study

  2026cites this paper
• Integrated bioinformatics-based identification of proliferative diabetic retinopathy and idiopathic pulmonary fibrosis: Focus on fibrosis and immune infiltration.

  2026cites this paper
• Novel OCT Angiography Parameters for Analyzing Microvascular Changes in Proliferative Diabetic Retinopathy After Intravitreal Conbercept Loading Injections.

  2026cites this paper
• Olink Proteomic Profiling of Vitreous Humor and Plasma From Proliferative Diabetic Retinopathy Patients Identifies a Novel Inflammatory Molecular Endotype

  2026cites this paper
• PFKFB3 nuclear translocation improves diabetic retinopathy by attenuating endothelial cell senescence through inhibition of USP7-p53 axis.

  2026cites this paper
• STAT1/SLC31A1 signaling promotes diabetic retinopathy progression by mediating cuproptosis-induced M1 polarization in microglial cells.

  2026cites this paper
• Sustained intraocular delivery of nintedanib via PLGA implant eradicates pathological angiogenesis in retinal neovascularization

  2026cites this paper
• Comparing widefield and ultra-widefield optical coherence tomography angiography with fluorescein angiography in diabetic retinopathy: a review

  2026cites this paper
• Exploration of Morphological Characteristics in Diabetic Macular Ischemia Utilizing a Large Language Model-Assisted Knowledge Graph.

  2026cites this paper
• Postural changes in retinal vascular parameters and risk of diabetic retinopathy progression in type 2 diabetes mellitus: a pilot study

  2026cites this paper
• Microaneurysm Reflectivity as a prognostic biomarker for intravitreal Treatment Response in Diabetic Retinopathy.

  2026cites this paper
• Implementation of diabetic retinopathy screening in the Oslo region, Norway: a 3-year pilot study

  2026cites this paper
• Biochemical–Cellular crosstalk in diabetes: exploring pathways driving microvascular complications

  2026cites this paper
• PERK inhibition attenuates multi-program cell death through Nrf2/HO-1 activation in diabetic retinopathy with integrated proteomics and functional validation in HRECs

  2026cites this paper
• Activated Protein C and the Retina: From Physiology to Therapeutic Potential

  2026cites this paper
• Retinal hypoxia is an early detection imaging biomarker for diabetic retinopathy.

  2026cites this paper
• Synergistic therapy for diabetic retinopathy via dual blockade of VEGF-A and TNF-α with a bispecific nanobody

  2026cites this paper
• Nailfold capillaroscopy for early detection of diabetic retinopathy: A non-invasive window into microvascular abnormalities

  2026cites this paper
• Relationship of OCT-Based Diabetic Retinal Neurodegeneration to the Development and Progression of Diabetic Retinopathy: A Cohort Study

  2025cites this paper
• Unraveling the causal role of sleep traits in development of diabetic retinopathy: A UK Biobank observational study and Mendelian randomization

  2025cites this paper
• Identifying Therapeutic Targets and Potential Drugs for Diabetic Retinopathy: Focus on Oxidative Stress and Immune Infiltration

  2025cites this paper
• Screening and evaluation of therapeutic candidates with vascular protective effects in zebrafish models of diabetic retinopathy

  2025cites this paper
• Oxidative Stress in Diabetic Retinopathy: A Comprehensive Review of Mechanisms, Biomarkers, and Therapeutic Perspectives

  2025cites this paper
• A Systematic Review on Whether Retinal Artery Microaneurysms Are Reliable Predictors of Coronary Artery Disease Severity

  2025cites this paper
• A trackable mitochondria-targeting nanosystem for mitochondrial redox and mitophagy regulation in diabetic retinopathy management

  2025cites this paper
• Intestinal neutrophil extracellular traps promote gut barrier damage exacerbating endotoxaemia, systemic inflammation and progression of diabetic retinopathy in type 2 diabetes

  2025cites this paper
• Retinal and Choriocapillaris Thickness Changes in Spontaneously Diabetic Macaques

  2025cites this paper
• Utilizing fundus images captured by two ultra-wide field imaging systems to measure diagnostic indicators and assess the grade of diabetic retinopathy

  2025cites this paper
• Resveratrol: potential therapeutic effects on ocular health

  2025cites this paper
• Diabetic retinopathy screening using machine learning: a systematic review

  2025cites this paper
• Prostaglandin E2 stimulates opposing effects on inner and outer blood-retina barrier function

  2025influential citation
• Proliferative diabetic retinopathy subtypes defined by immune defense and endothelial mitochondrial dysfunction

  2025cites this paper
• Leucine-rich α-2-glycoprotein 1 initiates the onset of diabetic retinopathy in mice

  2025cites this paper
• Baseline Optical Coherence Tomography Biomarkers Associated with Visual Acuity in Diabetic Macular Edema: A Systematic Review and Meta-Analysis.

  2025cites this paper
• Nanomedicine-Based Ophthalmic Drug Delivery Systems for the Treatment of Ocular Diseases

  2025cites this paper
• The long-range and short-range functional connectivity density of diabetic retinopathy and their spatial relationships with gene expression and neurotransmitters.

  2025cites this paper
• Analysis of Aqueous Interleukin-6 in Diabetic Retinopathy: A Prospective, Controlled Trial of 328 Eyes.

  2025cites this paper
• Effect of disease duration on foveal microvasculature assessed by OCTA in type 2 diabetes mellitus without clinical diabetic retinopathy

  2025cites this paper
• Understanding amblyopia from the perspective of neurovascular units: changes in the retina and brain

  2025cites this paper
• The Calcium Signalling Profile of the Inner Blood–Retinal Barrier in Diabetic Retinopathy

  2025cites this paper
• Understanding nonproliferative diabetic retinopathy progression using noninvasive imaging

  2025cites this paper
• Retinal Mid-Peripheral Capillary Free Zones Are Enlarged in Diabetic Patients With No Evidence of Clinical Retinopathy

  2025cites this paper
• The Role of Cytokines in Degenerative Retinal Diseases: A Comprehensive Review

  2025cites this paper
• Clinical characterization of 3-year progression of diabetic macular ischemia on OCT angiography

  2025cites this paper
• Mass spectrometry-based metabolomic and lipidomic profiling stratifies stages of diabetic retinopathy.

  2025cites this paper
• Claudin 5 Across the Vascular Landscape: From Blood–Tissue Barrier Regulation to Disease Mechanisms

  2025cites this paper
• Nrf2 Deficiency in Müller Cells Exacerbates Pathological Neovascularization in Ischemic Retinopathy.

  2025cites this paper
• Association between posterior vitreous detachment stage and quantitative neovascularization morphology in proliferative diabetic retinopathy using wide-field swept-source optical coherence tomography angiography.

  2025cites this paper
• Macrophage polarization in diabetic vascular complications: mechanistic insights and therapeutic targets

  2025cites this paper
• Diabetic Retinopathy in Focus: Update on Treatment Advances, Pharmaceutical Approaches, and New Technologies.

  2025cites this paper
• Transpupillary in vivo two-photon imaging reveals enhanced surveillance of retinal microglia in diabetic mice

  2025cites this paper
• OUTER RETINAL LAYER DETERIORATION PATTERNS IN EYES WITH DIABETIC SEROUS MACULAR DETACHMENT.

  2025cites this paper
• Specnuezhenide: Comprehensive review of pharmacology, pharmacokinetics and ethnomedicinal uses.

  2025cites this paper
• A systematic meta-analysis of the prevalence of diabetic retinopathy

  2025cites this paper
• Lipoxin A4 (LXA4) as a Potential Drug for Diabetic Retinopathy

  2025cites this paper
• Exacerbation of diabetes due to F. Nucleatum LPS-induced SGLT2 overexpression in the renal proximal tubular epithelial cells

  2025cites this paper
• Evaluating lipid-lowering drug targets for full-course diabetic retinopathy

  2025cites this paper
• Endothelial AGGF1 promotes retinal angiogenesis by coordinating TNFSF12/FN14 signalling

  2025cites this paper
• Anatomic Control with Faricimab versus Aflibercept in the YOSEMITE/RHINE Trials in Diabetic Macular Edema.

  2025cites this paper
• Short-Term Diabetic Retinopathy Status in People with Type 1 Diabetes Commencing Automated Insulin Delivery

  2025cites this paper
• Dual-Branch Network with Hybrid Attention for Multimodal Ophthalmic Diagnosis

  2025cites this paper
• Targeting Senescence, Oxidative Stress, and Inflammation: Quercetin-Based Strategies for Ocular Diseases in Older Adults

  2025cites this paper
• Polystyrene microplastics impair the function of human retinal microvascular endothelial cells and pericytes and increase vascular permeability in vitro

  2025cites this paper
• Metabolomic insights into vitreous humor with therapy outcome in type 2 diabetic retinopathy

  2025cites this paper
• Diabetic retinopathy—recommendations for screening and treatment

  2025cites this paper
• Hypoglycemia promotes inner blood-retinal barrier breakdown and retinal vascular leakage in diabetic mice.

  2025cites this paper
• C-reactive protein conformations and their association with the IL-1β/IL-6 pathway in ocular inflammatory conditions

  2025cites this paper
• Evaluation of the optic disk in diabetic patients using optical coherence tomography angiography

  2025cites this paper
• The Role of Non-coding RNAs in Diabetic Retinopathy: Mechanistic Insights and Therapeutic Potential

  2025cites this paper
• Frequency of Tumor Necrosis Factor-α, Interleukin-6, and Interleukin-10 Gene Polymorphisms in Mexican Patients with Diabetic Retinopathy and Diabetic Kidney Disease

  2025cites this paper
• A Deep Learning Segmentation Model for Detection of Active Proliferative Diabetic Retinopathy

  2025cites this paper
• Duration and Frequency of Lapses in Care Among Patients with Proliferative Diabetic Retinopathy

  2025cites this paper
• Neuroprotective Effect of a Novel Soluble Guanylate Cyclase Activator (sGCa) Runcaciguat in Diabetes and Ischemic Retinopathy.

  2025cites this paper
• Treatment Effects of Panretinal Photocoagulation or Combined Anti-Vascular Endothelial Growth Factor Therapy for Proliferative Diabetic Retinopathy on the Risks of Diabetic Macular Edema and Vitreous Hemorrhage

  2025cites this paper
• Diagnostic value of choroidal vascular density in predicting the progression of diabetic retinopathy

  2025cites this paper
• CAVIN3 deficiency promotes vascular normalization in ocular neovascular disease via ERK/JAG1 signaling pathway

  2025cites this paper
• Gut Microbiota Combined With Metabolomics to Reveal the Mechanism of Tang Wang Ming Mu Granule in the Treatment of Diabetic Retinopathy in Mice.

  2025cites this paper
• Metabolomic biomarkers in vitreous humor: unveiling the molecular landscape of diabetic retinopathy progression

  2025cites this paper
• Oral lamivudine in diabetic macular edema: A randomized, double-blind, placebo-controlled clinical trial.

  2025cites this paper
• Diabetes-Driven Retinal Neurodegeneration: Its Role in the Pathogenesis of Diabetic Retinopathy

  2025cites this paper
• Vision Loss as a Rising Global Health Challenge: Comprehensive Analysis of High Fasting Plasma Glucose Burden and Projections to 2035

  2025cites this paper
• Universal nomogram for predicting referable diabetic retinopathy: a validated model for community and ophthalmic outpatient populations using easily accessible indicators

  2025cites this paper
• BCAT1 Activation Reprograms Branched-Chain Amino Acid Metabolism and Epigenetically Promotes Inflammation in Diabetic Retinopathy

  2025cites this paper
• Fenofibrate Exerts Protective Effects in Diabetic Retinopathy

  2025cites this paper
• Mediating role of sleep quality in the relationship between diabetes mellitus and visual function: a cross-sectional study

  2025cites this paper
• Causal Relationship Between Various Vitamins and Different Diabetic Complications: A Mendelian Randomization Study

  2025cites this paper
• Predictive Model for Proliferative Diabetic Retinopathy Using Single-Cell Transcriptomics.

  2025cites this paper
• Synthetic microneurotrophins: Neurotrophin receptors for therapeutics of neurodegenerative diseases

  2025cites this paper
• Association of serum proinflammatory factors with clinical response to ranibizumab for diabetic macular edema

  2025cites this paper
• ATG16L1 promotes cell migration and invasion in high glucose–induced retinal capillary endothelial cells

  2025cites this paper
• Novel Optical Imaging Probe for the Targeted Visualization of NLRP3 Inflammasomes in Living Retina

  2025cites this paper
• The Influence of Ultra-Widefield Fluorescein Angiography on the Diagnosis and Management of Diabetic Retinopathy

  2025cites this paper
• Tissue origin of endothelial cells determines immune system modulation and regulation of HIF-1α-, TGF-β-, and VEGF signaling

  2025cites this paper
• Cdc42 is crucial for mural cell migration, proliferation and patterning of the retinal vasculature.

  2025cites this paper
• Metabolic Deficiencies in the Vitreous of Diabetic Retinopathy: Exploring the Potential of Dietary Supplementation to Address Key Metabolite Imbalances

  2025cites this paper
• High expression of Mrps10 in diabetic retinopathy: A bioinformatics analysis based on public transcriptomic data

  2025cites this paper
• Diabetic retinal disease

  2025cites this paper
• Physiology and pathophysiology of the retinal neuroglia.

  2025cites this paper